| Nuvasive is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Co.'s principal product offering includes a minimally disruptive surgical platform, Maximum Access Surgery. The platform includes Co.'s proprietary software-driven nerve detection and avoidance systems, and Intraoperative Monitoring services and support; MaXcess, an integrated split-blade retractor system; and implants and biologics. Co.'s spine surgery product line offerings, which include products for the thoracolumbar and the cervical spine, are used to enable surgeon access to the spine to perform restorative and fusion procedures. We show 42 historical shares outstanding datapoints in our NUVA shares outstanding history coverage, used to compute NUVA market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NUVA market cap history over the course of time is important for investors
interested in comparing NUVA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NUVA versus a peer is one thing; comparing
NUVA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NUVA can fluctuate over the course of history.
With this page we aim to empower investors researching NUVA by allowing them to research the NUVA market cap history.